NCT03746470

Brief Summary

This is a prospective and randomized trial to compare two different techniques used in normal practice for the reconstruction of the anterior cruciate ligament in arthroscopy. The experimental group (group 1) will undergo a reconstruction technique where semitendinosus and gracilis will preserve their insertion at the level of the hamstring whereas in the control group (group 2) the semitendinosus and gracilis tendons will be disengaged from their insertion on the hamstring .

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 22, 2018

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

October 30, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 19, 2018

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2024

Completed
Last Updated

August 6, 2025

Status Verified

August 1, 2025

Enrollment Period

5.9 years

First QC Date

October 30, 2018

Last Update Submit

August 5, 2025

Conditions

Keywords

arthroscopy

Outcome Measures

Primary Outcomes (1)

  • Graft integration by the Signal / Noise Quotient (SNQ) at 6 months

    Signal intensity of the graft evaluated by the Signal / Noise Quotient (SNQ) during MRI 3 Tesla

    6 months after ACL reconstruction intervention

Secondary Outcomes (6)

  • Graft integration by the Signal / Noise Quotient (SNQ) at 3 and 12 months

    3, 12 months after ACL reconstruction intervention

  • Right anatomical graft position

    12 months after ACL reconstruction intervention

  • Anterior tibial translation

    3, 6, 12 months after ACL reconstruction intervention

  • Anterior knee joint instability

    3, 6, 12 months after ACL reconstruction intervention

  • IKDC (International Knee Documentation Committee) questionnaire

    3, 6, 12 months after ACL reconstruction intervention

  • +1 more secondary outcomes

Study Arms (2)

insertion preserving

EXPERIMENTAL

ACL reconstruction preserving insertion

Procedure: ACL reconstruction preserving insertion

insertion detaching

ACTIVE COMPARATOR

ACL reconstruction detaching insertion

Procedure: ACL reconstruction detaching insertion

Interventions

Anterior cruciate ligament reconstruction with semitendinosus and gracilis, preserving their insertion at the level of the hamstring.

insertion preserving

Anterior cruciate ligament reconstruction with semitendinosus and gracilis tendons completely detached from their insertion at the hamstring.

insertion detaching

Eligibility Criteria

Age16 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age between 18 and 55
  • MRI confirmed primary and total ACL injury of traumatic origin
  • Indication for ACL reconstruction in arthroscopy
  • Written informed consent
  • Active and non-sedentary lifestyle

You may not qualify if:

  • Complex meniscal injuries
  • Cartilage lesions of sizes\> 2 cm2
  • Other ligamentous lesions
  • Axis deviations greater than 10°
  • Rheumatic, neuromuscular or general systemic diseases
  • Prevention of injured knee traumas treated surgically
  • Difficulties in compliance in following the rehabilitation programs
  • Obesity (BMI ≥ 30)
  • Neoplastic diseases, metabolic diseases, inflammatory and systemic diseases, autoimmune diseases, immunocompromised patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

IRCCS Istituto Ortopedico Rizzoli

Bologna, Italy

Location

EOC - Unità Traumatologia e Ortopedia ORL

Lugano, Switzerland

Location

Study Officials

  • Marco Decogliano, MD

    EOC - Unità Traumatologia e Ortopedia - ORL

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2018

First Posted

November 19, 2018

Study Start

October 22, 2018

Primary Completion

September 29, 2024

Study Completion

September 29, 2024

Last Updated

August 6, 2025

Record last verified: 2025-08

Locations